FindBook      Google Book      Amazon      博客來     
  • Gene therapy of cancer = translational approaches from preclinical studies to clinical implementation /
  • 紀錄類型: 書目-電子資源 : Monograph/item
    正題名/作者: Gene therapy of cancer/ edited by Edmund C. Lattime, Stanton L. Gerson.{me_controlnum}
    其他題名: translational approaches from preclinical studies to clinical implementation /
    其他作者: Lattime, Edmund C.,
    出版者: San Diego, CA :Academic Press, : c2002.,
    面頁冊數: 1 online resource (xix, 534 p.) :ill. (some col.)
    內容註: Ch. 1. Retroviral vector design for cancer gene therapy -- Ch. 2. Noninfectious gene transfer and expression systems for cancer gene therapy -- Ch. 3. Parvovirus vectors for the gene therapy of cancer -- Ch. 4. Antibody-targeted gene therapy -- Ch. 5. Ribozymes in cancer gene therapy -- Ch. 6. The advent of lentiviral vectors: prospects for cancer therapy -- Ch. 7. Immunologic targets for the gene therapy of cancer -- Ch. 8. Development of epitope-specific immunotherapies for human malignancies and premalignant lesions expressing mutated ras genes -- Ch. 9. Introduction to dendritic cells -- Ch. 10. DNA and dendritic cell-based genetic immunization against cancer -- Ch. 11. RNA-transfected dendritic cells as immunogens -- Ch. 12. In Situ immune modulation using recombinant vaccinia virus vectors: preclinical studies to clinical implementation -- Ch. 13. The use of particle-mediated gene transfer for immunotherapy of cancer -- Ch. 14. Applications of gene transfer in the adoptive immunotherapy of cancer -- Ch. 15. Update on the use of genetically modified hematopoietic stem cells for cancer therapy -- Ch. 16. Clinical applications of tumor-suppressor gene therapy -- Ch. 17. Cancer gene therapy with tumor suppressor genes involved in cell-cycle control.
    內容註: Ch. 18. Cancer gene therapy with the p53 tumor suppressor gene -- Ch. 19. Antisense downregulation of the apoptosis-related Bcl-2 and Bcl-xl proteins: a new approach to cancer therapy -- Ch. 20. Gene therapy for chronic myelogenous leukemia -- Ch. 21. Transfer of drug-resistance genes into hematopoietic progenitors -- Ch. 22. Multidrug-resistance gene therapy in hematopoietic cell transplantation -- Ch. 23. Development and application of an engineered dihydrofolate reductase and cytidine-deaminase-based fusion genes in myeloprotection-based gene therapy strategies -- Ch. 24. Protection from antifolate toxicity by expression of drug-resistant dihydrofolate reductase -- Ch. 25. A genomic approach to the treatment of breast cancer -- Ch. 26. Antiangiogenic gene therapy -- Ch. 27. VEGF-targeted antiangiogenic gene therapy -- Ch. 28. Strategies for combining gene therapy with ionizing radiation to improve antitumor efficacy -- Ch. 29. Virotherapy with replication-selective oncolytic adenoviruses: a novel therapeutic platform for cancer -- Ch. 30. E1A cancer gene therapy -- Ch. 31. Preemptive and therapeutic uses of suicide genes for cancer and leukemia -- Ch. 32. Treatment of mesothelioma using adenoviral-mediated delivery of herpes simplex virus thymidline kinase gene in combination with ganciclovir -- Ch. 33. The use of suicide gene therapy for the treatment of malignancies of the brain -- Ch. 34. Case study of combined gene and radiation therapy as an approach in the treatment of cancer.
    標題: Cancer - Gene therapy. -
    電子資源: http://www.sciencedirect.com/science/book/9780124375512
    ISBN: 9780124375512
館藏地:  出版年:  卷號: 
館藏
  • 1 筆 • 頁數 1 •
 
W9148776 電子資源 11.線上閱覽_V 電子書 EB RC271.G45 G485 2002eb 一般使用(Normal) 在架 0
  • 1 筆 • 頁數 1 •
多媒體
評論
Export
取書館
 
 
變更密碼
登入